ACAD - ACADIA Pharmaceuticals Stock Trading

ACADIA Pharmaceuticals Inc.(NASDAQ: ACAD) stock trading, description, contact, officers and directors.

About ACADIA Pharmaceuticals Inc.

None

Stock Information

ACADIA Pharmaceuticals Inc. Company Name:

ACAD Stock Symbol:

NASDAQ Market:

Get ACAD Alerts

News, Short Squeeze, Breakout and More Instantly...

RECENT ACAD NEWS

ACAD - ACADIA Pharmaceuticals to Combine CLARITY-2 and CLARITY-3 Phase 3 Studies Evaluating Pimavanserin for the Adjunctive Treatment of Major Depressive Disorder

- Top-line results expected in 3Q20 ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that following positive feedback from the U.S. Food and Drug Administration the company plans to combine its CLARITY-2 and CLARITY-3 Phase 3 studies evaluating pimavanserin for the adjunctive...
ACAD - ACADIA Pharmaceuticals to Present Pimavanserin Clinical Data at the 2020 American Society of Clinical Psychopharmacology Virtual Annual Meeting

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that multiple scientific presentations and abstracts evaluating pimavanserin in clinical studies for the treatment of various central nervous system (CNS) disorders will be highlighted at the 2020 American Society of Clinical Psychoph...
ACAD - Is Amarin Stock a Buy?

Irish biopharmaceutical company Amarin (NASDAQ: AMRN) posted record revenue of $155 million in its first-quarter earnings reported April 30, marking an 112% year-over-year increase for a net loss of $20.6 million, or $0.06 per share. The company's sole product, Vascepa, is a drug derive...